𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Factors predicting response to dopaminergic treatment for resting tremor of Parkinson's disease

✍ Scribed by Young H. Sung; Sun J. Chung; Sung R. Kim; Myoung C. Lee

Publisher
John Wiley and Sons
Year
2008
Tongue
English
Weight
62 KB
Volume
23
Category
Article
ISSN
0885-3185

No coin nor oath required. For personal study only.

✦ Synopsis

Abstract

We aimed to evaluate the clinical factors predicting response to dopaminergic treatment for resting tremor in patients with Parkinson's disease (PD). Eighty‐five PD patients with prominent resting tremor, defined as tremors of score greater than 3 in at least one limb on the Unified Parkinson's Disease Rating Scale (UPDRS), were divided into those responsive or nonresponsive to dopaminergic treatment. Responsiveness was defined as a reduction of at least two points for more than 3 months in the UPDRS tremor score. Of the 85 patients, 36 (42.4%) were responsive and 49 (57.6%) were nonresponsive to dopaminergic treatment. Initial UPDRS III score (P = 0.015) and Hoehn and Yahr stage (P = 0.010) were each significantly higher in the RG than in the NRG. UPDRS subscores for rigidity (P = 0.012), bradykinesia (P = 0.021) and postural impairment (P = 0.018) also correlated with responsiveness to dopaminergic treatment. Resting tremor in PD patients was more responsive to dopaminergic treatment when accompanied by moderate degrees of bradykinesia and rigidity than in patients without other prominent parkinsonian features. Β© 2007 Movement Disorder Society

πŸ“œ SIMILAR VOLUMES

Dopaminergic responsiveness to apomorphi
Dopaminergic responsiveness to apomorphine after chronic treatment with subcutaneous lisuride infusion in Parkinson's disease
✍ J. Vaamonde; M. R. Luquin; Dr. J. A. Obeso πŸ“‚ Article πŸ“… 1990 πŸ› John Wiley and Sons 🌐 English βš– 249 KB

## Abstract The aim of this study was to assess whether or not continuous infusion of lisuride in combination with intermittent levodopa‐carbidopa administration was associated with tolerance. Intravenous apomorphine was given to four patients before initiation of chronic treatment with subcutaneou

Predictors of time to requiring dopamine
Predictors of time to requiring dopaminergic treatment in 2 Parkinson's disease cohorts
✍ Connie Marras; Michael P. McDermott; Ken Marek; Paula Rochon; Gary Naglie; Carol πŸ“‚ Article πŸ“… 2011 πŸ› John Wiley and Sons 🌐 English βš– 101 KB πŸ‘ 1 views

## Abstract The rate of progression of Parkinson's disease (PD) is highly variable. Knowledge of factors associated with disease milestones and commonly used research outcome measures helps with patient counseling and guides the design and interpretation of clinical studies. The objective of the st

Differential response of speed, amplitud
Differential response of speed, amplitude, and rhythm to dopaminergic medications in Parkinson's disease
✍ Alberto J. Espay; Joe P. Giuffrida; Robert Chen; Megan Payne; Filomena Mazzella; πŸ“‚ Article πŸ“… 2011 πŸ› John Wiley and Sons 🌐 English βš– 231 KB πŸ‘ 1 views

## Abstract Although movement impairment in Parkinson's disease includes slowness (bradykinesia), decreased amplitude (hypokinesia), and dysrhythmia, clinicians are instructed to rate them in a combined 0–4 severity scale using the Unified Parkinson's Disease Rating Scale motor subscale. The object

Pathological gambling behaviour: Emergen
Pathological gambling behaviour: Emergence secondary to treatment of Parkinson's disease with dopaminergic agents
✍ Soraya Seedat; Simon Kesler; Dana J.H. Niehaus; Dan J. Stein πŸ“‚ Article πŸ“… 2000 πŸ› John Wiley and Sons 🌐 English βš– 38 KB πŸ‘ 2 views

We present a case in which the use of low dose risperidone (a potent D2 and 5-HT2 antagonist) was successful in controlling gambling behaviour secondary to dopamine agonist treatment of Parkinson's disease. Pharmacotherapeutic management of pathological gambling secondary to medical causes deserves